• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 PD-1 治疗与晚期黑色素瘤患者治疗相关的心脏不良事件:肌钙蛋白 T 水平检测的意义。

Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels.

机构信息

Department of Oncodermatology, Université de Nantes, CHU Nantes, CIC 1413, CRCINA, Nantes, France.

Department of Epidemiology and Biostatistics, CHU Nantes, CRCINA, INSERM 1232, Université de Nantes, Nantes, France.

出版信息

Eur J Dermatol. 2021 Apr 1;31(2):205-212. doi: 10.1684/ejd.2021.4009.

DOI:10.1684/ejd.2021.4009
PMID:33814359
Abstract

BACKGROUND

Immune checkpoint inhibitors have improved the management of metastatic melanoma, however, we have witnessed an emergence of adverse cardiac events such as myocarditis.

OBJECTIVES

We first aimed to assess the prevalence of adverse cardiac events in patients treated with anti-PD-1 for metastatic melanoma. Our second objective was to determine the role of troponin monitoring in the diagnosis of these events.

MATERIALS & METHODS: We retrospectively analysed the prevalence of patients treated with anti-PD-1 in a real-life setting based on a cohort of 183 patients. We then performed a prospective cohort, in which clinical and biological profiles of patients were collected, along with monthly monitoring of troponin levels.

RESULTS

The prevalence of adverse cardiac events in the retrospective cohort was 2.2%, with three cases of myocarditis and one of myocardial infarction. In the prospective cohort, 14/52 patients had an abnormal baseline troponin T level. All patients had a history of cardiac or vascular complaints. Six patients showed an increase in troponin T level during follow-up, in two patients associated with clinical symptoms.

CONCLUSION

Adverse cardiac events with immunotherapy are both frequent and life-threatening. Troponin T may be of interest to detect early adverse cardiac events before any clinical sign, however, the data supporting this remain to be confirmed.

摘要

背景

免疫检查点抑制剂改善了转移性黑色素瘤的治疗效果,但同时也出现了心肌炎等不良心脏事件。

目的

我们首先旨在评估抗 PD-1 治疗转移性黑色素瘤患者不良心脏事件的发生率。我们的第二个目标是确定肌钙蛋白监测在这些事件诊断中的作用。

材料与方法

我们回顾性分析了基于 183 例患者队列的真实环境中接受抗 PD-1 治疗的患者的不良心脏事件发生率。然后,我们进行了前瞻性队列研究,收集了患者的临床和生物学特征,并每月监测肌钙蛋白水平。

结果

回顾性队列中不良心脏事件的发生率为 2.2%,包括 3 例心肌炎和 1 例心肌梗死。在前瞻性队列中,52 例患者中有 14 例基线肌钙蛋白 T 水平异常。所有患者均有心脏或血管疾病的病史。在随访期间,有 6 例患者的肌钙蛋白 T 水平升高,其中 2 例伴有临床症状。

结论

免疫治疗相关的不良心脏事件既常见又危及生命。肌钙蛋白 T 可能有助于在任何临床症状出现之前检测早期不良心脏事件,但支持这一点的数据仍需确认。

相似文献

1
Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels.抗 PD-1 治疗与晚期黑色素瘤患者治疗相关的心脏不良事件:肌钙蛋白 T 水平检测的意义。
Eur J Dermatol. 2021 Apr 1;31(2):205-212. doi: 10.1684/ejd.2021.4009.
2
A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.深入探讨联合检查点阻断和靶向治疗时代的免疫介导性心肌炎。
Eur J Cancer. 2020 Jan;124:15-24. doi: 10.1016/j.ejca.2019.09.009.
3
Troponin increase during immunotherapy: Not always myocarditis.免疫治疗期间肌钙蛋白升高:并非总是由心肌炎引起。
Eur J Cancer. 2021 Nov;157:424-427. doi: 10.1016/j.ejca.2021.08.040. Epub 2021 Sep 28.
4
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma.抗程序性细胞死亡蛋白 1 抗体治疗与转移性黑色素瘤患者接受伊匹单抗免疫相关不良反应后毒性作用复发风险的相关性。
JAMA Dermatol. 2020 Sep 1;156(9):982-986. doi: 10.1001/jamadermatol.2020.2149.
5
Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients.免疫检查点抑制剂治疗相关心肌炎:三例病例报告。
Emerg Radiol. 2020 Aug;27(4):455-460. doi: 10.1007/s10140-020-01765-6. Epub 2020 Mar 4.
6
Prospective cardiovascular events in patients with advanced thoracic cancer treated with immune checkpoint inhibitor.晚期胸部恶性肿瘤患者接受免疫检查点抑制剂治疗后的预期心血管事件。
Eur J Cancer. 2024 Aug;207:114191. doi: 10.1016/j.ejca.2024.114191. Epub 2024 Jun 24.
7
Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice.新型PD-1抑制剂普罗戈利单抗:拓展不可切除/转移性黑色素瘤的治疗选择
Eur J Cancer. 2021 May;149:222-232. doi: 10.1016/j.ejca.2021.02.030. Epub 2021 Apr 17.
8
Immune Checkpoint Inhibitor Myocarditis With Normal Cardiac Magnetic Resonance Imaging: Importance of Cardiac Biopsy and Early Diagnosis.心脏磁共振成像正常的免疫检查点抑制剂相关性心肌炎:心脏活检及早期诊断的重要性
Can J Cardiol. 2021 Oct;37(10):1654-1656. doi: 10.1016/j.cjca.2020.12.022. Epub 2020 Dec 26.
9
Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.重新引入免疫疗法治疗免疫检查点抑制剂介导心肌炎后存活的患者。
Clin Res Cardiol. 2021 Jan;110(1):50-60. doi: 10.1007/s00392-020-01648-3. Epub 2020 Apr 15.
10
Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update.免疫检查点阻断治疗转移性黑色素瘤中 CTLA-4 和 PD-1 抗体的副作用管理 - 最新进展。
J Dtsch Dermatol Ges. 2020 Jun;18(6):582-609. doi: 10.1111/ddg.14128. Epub 2020 Jun 3.

引用本文的文献

1
Immunotherapy-Associated Cardiotoxicity: Current Insights and Future Directions for Precision Cardio-Oncology.免疫治疗相关心脏毒性:精准心脏肿瘤学的当前见解与未来方向
Cancers (Basel). 2025 Aug 29;17(17):2838. doi: 10.3390/cancers17172838.
2
Dynamic cardiac changes in low cardiovascular risk patients with triple negative breast cancer treated with chemo-immunotherapy.接受化疗免疫治疗的三阴性乳腺癌低心血管风险患者的动态心脏变化
Cardiooncology. 2025 Jul 3;11(1):62. doi: 10.1186/s40959-025-00361-2.
3
Unmasking the Rare but Lethal Cardiac Complications of Immune Checkpoint Inhibitor Therapy: A Review of Mechanisms, Risk Factors, and Management Strategies.
揭示免疫检查点抑制剂治疗罕见但致命的心脏并发症:机制、危险因素及管理策略综述
Curr Treat Options Oncol. 2025 May 24. doi: 10.1007/s11864-025-01329-1.
4
Risk Factors for Immune Checkpoint Inhibitor-Mediated Cardiovascular Toxicities.免疫检查点抑制剂相关心血管毒性的危险因素。
Curr Oncol Rep. 2023 Jul;25(7):753-763. doi: 10.1007/s11912-023-01414-4. Epub 2023 Apr 20.
5
Myocarditis Induced by Immunotherapy in Metastatic Melanoma-Review of Literature and Current Guidelines.免疫疗法诱发的转移性黑色素瘤相关性心肌炎——文献综述与现行指南
J Clin Med. 2022 Sep 1;11(17):5182. doi: 10.3390/jcm11175182.